Long non-coding RNA HULC as a diagnostic and prognostic marker of pancreatic cancer

Figure 1 Distinguishing between patients with pancreatic cancer, patients with benign diseases and healthy subjects using HULC. A: Expression of HULC in pancreatic cancer tissues and tumor-adjacent tissues; B: Expression of serum HULC in the 3 groups; C: Correlation between pancreatic cancer tissues and expression of serum HULC; D: ROC curve of serum HULC for distinguishing patients with pancreatic cancer from those with benign diseases; E: ROC curve of serum HULC for distinguishing patients with pancreatic cancer from healthy subjects; F: ROC curve of serum HULC for distinguishing patients with benign diseases from healthy subjects. ^bP < 0.01, ^dP < 0.01 for between-group comparisons. ROC: Receiver operating characteristic.